Oak Longevity vs bmiMD: Pricing, meds, and commitment compared
Oak Longevity vs bmiMD: which telehealth option fits you depends on price structure, medication choice, clinical access, and commitment length. Early verdict: Oak Longevity is the lower month to month price with no subscription required, while bmiMD offers lower long term monthly equivalents in exchange for multi month commitments.
See Oak Longevity pricing and options
Head to head: the main differences at a glance
This comparison focuses on the most distinctive supported differences: price and billing model, medication selection, clinical access and review style, commitment and refund terms, and regulatory status. The primary keyword Oak Longevity vs bmiMD appears throughout to help you compare quickly.
1. Pricing and billing model
Oak Longevity lists semaglutide starting at $133 per month and tirzepatide from $199 per month, with one flat price covering all dosages and no subscription required. Oak bills monthly on a non recurring basis; three month prescriptions are billed upfront and Oak states no refunds after physician approval and once medication has shipped.
bmiMD offers compounded tirzepatide with four billing options and multi month pricing: $179 month to month, $159 per month for three months, $149 per month for six months, and $139 per month for a 12 month plan. bmiMD advertises lower long term monthly equivalents but the lowest price requires a 12 month commitment and total prepaid charge should be confirmed.
2. Medication selection and dosing price approach
Oak Longevity sells both compounded semaglutide and compounded tirzepatide and emphasizes a one price covers all dosages approach. bmiMD is captured offering compounded tirzepatide specifically with the same price at every dose and tiered monthly equivalents for multi month plans. If you want semaglutide specifically, Oak lists semaglutide from $133/mo while bmiMD evidence focuses on tirzepatide pricing.
Check Oak Longevity medication options
3. Clinical access and review process
Oak Longevity operates with an asynchronous clinical review where patients complete a short online health questionnaire and a licensed physician reviews information without a required video call. Oak notes board certified physicians in your state review every case and same day approval is available for qualifying patients. bmiMD highlights 24/7 clinician access and online refills and delivery, and requires treatment only when a licensed clinician determines it is medically appropriate.
4. Commitments, refunds, and shipping
Oak emphasizes no subscriptions, no membership fees, free shipping, and free health coaching. Oak states you are not auto charged and choose to renew payment each month; three month prescriptions are billed upfront and no refunds are available after physician approval and once medication has shipped. bmiMD states free shipping on every subscription order and advertises a 100 percent refund if not eligible for the program, while noting the lowest monthly price requires longer prepaid commitments.
5. Regulatory status and suitability
Both providers offer compounded medications and both sources include the regulatory note that compounded medications are not FDA approved finished products and are not reviewed by the FDA for safety, effectiveness or quality. Oak includes specific suitability notes: not appropriate for patients under 18, pregnant, or nursing and patients with BMI below 20 do not qualify for GLP 1 treatment; another Oak note says not appropriate for BMI under 22 without comorbidities. bmiMD does not supply expanded eligibility details in the captured evidence beyond clinician determination and availability subject to the live offer.
| Criteria | Oak Longevity | bmiMD |
|---|---|---|
| Starting monthly price | Semaglutide from $133; Tirzepatide from $199 | Tirzepatide: $179 month to month; as low as $139 with 12 month plan |
| Billing model | One flat price, no subscription; optional 3 month billed upfront | Subscription tiers with 1, 3, 6, 12 month plans and lower long term equivalents |
| Medications offered | Compounded semaglutide and tirzepatide | Compounded tirzepatide |
| Clinical access | Asynchronous clinician review, no required video call; board certified physicians review cases | 24/7 clinician access; online refills and delivery |
| Shipping and refunds | Free shipping; no refunds after physician approval and once medication has shipped | Free shipping on subscription orders; 100 percent refundable if not eligible for program |
| Regulatory note | Compounded medications are not FDA approved finished products | Compounded medications are not FDA approved finished products |
How to decide: Choose based on price, meds, and commitment
Oak Longevity vs bmiMD comes down to whether you prioritize lower month to month pricing with no subscription or lower long term monthly equivalents tied to prepaid commitments. Clinical access style and whether you need semaglutide versus tirzepatide are also decisive.
Explore bmiMD plans and commitments
Start with Oak Longevity details
Choose Oak Longevity if…
- You want semaglutide availability and the lowest listed month to month price for semaglutide and tirzepatide with one flat price and no subscription required.
- You prefer asynchronous clinician review without a required video call, free health coaching, and free shipping.
Choose bmiMD if…
- You plan to commit to multi month prepaid plans to reach a lower long term monthly equivalent and value 24/7 clinician access and online refills.
Primary keyword: Oak Longevity vs bmiMD. Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications are not FDA approved finished products.